Altered cardiovascular regulation in arginine vasopressin-overexpressing transgenic rat. 2003

Kazushige Tachikawa, and Hisashi Yokoi, and Hiroshi Nagasaki, and Hiroshi Arima, and Takashi Murase, and Yoshihisa Sugimura, and Yoshitaka Miura, and Masumi Hirabayashi, and Yutaka Oiso
Department of of Internal Medicine, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.

Although arginine vasopressin (AVP), an antidiuretic hormone, has been widely acknowledged to play an important role in cardiovascular regulation via V1a receptors (V1aR), its precise significance remains unclear. In this study, we investigated the effects of long-standing high plasma AVP status on cardiovascular regulation in the AVP-overexpressing transgenic (Tg) rat. Adult male homozygous Tg rats were compared with age-matched normal Sprague-Dawley rats as controls. There were no significant differences in mean arterial blood pressure (BP; MABP) or heart rate between Tg and control rats in the basal state. Subcutaneous injection of AVP significantly increased MABP in controls but did not cause any apparent increase in MABP in Tg rats. BP recovery from hemorrhage-induced hypotension was significantly delayed in Tg compared with control rats. Pretreatment with a selective V1aR antagonist, OPC-21268, which is thought to restore the downregulation of V1aR, markedly improved both of these impaired responses. Northern blot analysis confirmed that decreased expression of V1aR mRNA and pretreatment with V1aR antagonist significantly restored the downregulation of V1aR mRNA. These results suggest that the Tg rat has decreased sensitivity to the hypertensive effect of AVP due to downregulation of V1aR, which may function as an adaptive mechanism to maintain normal BP against chronic hypervasopressinemia. In addition, impaired restoration of BP after hemorrhage-induced hypotension in Tg rats supports a physiological role of AVP in cardiovascular regulation.

UI MeSH Term Description Entries
D008297 Male Males
D010880 Piperidines A family of hexahydropyridines.
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002340 Carotid Artery Diseases Pathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology. Carotid Atherosclerosis,Common Carotid Artery Disease,Internal Carotid Artery Disease,Arterial Diseases, Carotid,Arterial Diseases, Common Carotid,Arterial Diseases, External Carotid,Arterial Diseases, Internal Carotid,Atherosclerotic Disease, Carotid,Carotid Artery Disorders,Carotid Atherosclerotic Disease,Common Carotid Artery Diseases,External Carotid Artery Diseases,Internal Carotid Artery Diseases,Arterial Disease, Carotid,Artery Disease, Carotid,Artery Diseases, Carotid,Artery Disorder, Carotid,Artery Disorders, Carotid,Atherosclerotic Diseases, Carotid,Carotid Arterial Disease,Carotid Arterial Diseases,Carotid Artery Disease,Carotid Artery Disorder,Carotid Atheroscleroses,Carotid Atherosclerotic Diseases,Disorders, Carotid Artery
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006487 Hemostasis The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION. Hemostases
D000222 Adaptation, Physiological The non-genetic biological changes of an organism in response to challenges in its ENVIRONMENT. Adaptation, Physiologic,Adaptations, Physiologic,Adaptations, Physiological,Adaptive Plasticity,Phenotypic Plasticity,Physiological Adaptation,Physiologic Adaptation,Physiologic Adaptations,Physiological Adaptations,Plasticity, Adaptive,Plasticity, Phenotypic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001127 Arginine Vasopressin The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Argipressin,Vasopressin, Arginine,Arg-Vasopressin,Argipressin Tannate,Arg Vasopressin
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone

Related Publications

Kazushige Tachikawa, and Hisashi Yokoi, and Hiroshi Nagasaki, and Hiroshi Arima, and Takashi Murase, and Yoshihisa Sugimura, and Yoshitaka Miura, and Masumi Hirabayashi, and Yutaka Oiso
May 1993, Molecular endocrinology (Baltimore, Md.),
Kazushige Tachikawa, and Hisashi Yokoi, and Hiroshi Nagasaki, and Hiroshi Arima, and Takashi Murase, and Yoshihisa Sugimura, and Yoshitaka Miura, and Masumi Hirabayashi, and Yutaka Oiso
April 1993, Neuroendocrinology,
Kazushige Tachikawa, and Hisashi Yokoi, and Hiroshi Nagasaki, and Hiroshi Arima, and Takashi Murase, and Yoshihisa Sugimura, and Yoshitaka Miura, and Masumi Hirabayashi, and Yutaka Oiso
June 1989, Endocrinology,
Kazushige Tachikawa, and Hisashi Yokoi, and Hiroshi Nagasaki, and Hiroshi Arima, and Takashi Murase, and Yoshihisa Sugimura, and Yoshitaka Miura, and Masumi Hirabayashi, and Yutaka Oiso
July 1990, The Journal of clinical investigation,
Kazushige Tachikawa, and Hisashi Yokoi, and Hiroshi Nagasaki, and Hiroshi Arima, and Takashi Murase, and Yoshihisa Sugimura, and Yoshitaka Miura, and Masumi Hirabayashi, and Yutaka Oiso
July 2000, Diabetologia,
Kazushige Tachikawa, and Hisashi Yokoi, and Hiroshi Nagasaki, and Hiroshi Arima, and Takashi Murase, and Yoshihisa Sugimura, and Yoshitaka Miura, and Masumi Hirabayashi, and Yutaka Oiso
January 1995, Peptides,
Kazushige Tachikawa, and Hisashi Yokoi, and Hiroshi Nagasaki, and Hiroshi Arima, and Takashi Murase, and Yoshihisa Sugimura, and Yoshitaka Miura, and Masumi Hirabayashi, and Yutaka Oiso
November 2020, Journal of physiology and biochemistry,
Kazushige Tachikawa, and Hisashi Yokoi, and Hiroshi Nagasaki, and Hiroshi Arima, and Takashi Murase, and Yoshihisa Sugimura, and Yoshitaka Miura, and Masumi Hirabayashi, and Yutaka Oiso
January 2021, Translational psychiatry,
Kazushige Tachikawa, and Hisashi Yokoi, and Hiroshi Nagasaki, and Hiroshi Arima, and Takashi Murase, and Yoshihisa Sugimura, and Yoshitaka Miura, and Masumi Hirabayashi, and Yutaka Oiso
January 1998, Progress in brain research,
Kazushige Tachikawa, and Hisashi Yokoi, and Hiroshi Nagasaki, and Hiroshi Arima, and Takashi Murase, and Yoshihisa Sugimura, and Yoshitaka Miura, and Masumi Hirabayashi, and Yutaka Oiso
October 2002, American journal of physiology. Heart and circulatory physiology,
Copied contents to your clipboard!